Página principal > Artículos > Resultados de la búsqueda: càncer.

Artículos

  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:

No se han encontrado coincidencias con cancer., pero utilizando en su lugar cancer ...
Artículos Encontrados 744 registros  inicioanterior113 - 122siguientefinal  ir al registro: La búsqueda tardó 0.04 segundos. 
113.
8 p, 1.0 MB Expression Patterns of miR181a and miR30d in Patients with Breast Cancer / Tavakolpournegari, Alireza (Islamic Azad University) ; Hashemi, Mehrdad (Islamic Azad University) ; Zare Karizi, Shohreh (Islamic Azad University) ; Matin Ahmadi, Arash (Nicolaus Copernicus University) ; Bidooki, Seyed Hesamoddin (University of Zaragoza) ; Banaei, Gooya (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
One of the important molecular pathways in breast cancer is the PTEN-PI3K-AKT pathway. Any change in the activity of the PTEN gene can alter the PI3K-AKT pathway. Moreover, there are subsets of genes and pathways their expression changes by post-transcriptional regulations. [...]
2022 - 10.18502/ijph.v51i7.10093
Iranian Journal of Public Health, Vol. 51, Num. 7 (July 2022) , p. 1594-1601  
Registro completo - Creative Commons
114.
14 p, 2.2 MB A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Early detection of PCa (PCa) has evolved towards clinically significant PCa (csPCa) after the spread of pre-biopsy multiparametric magnetic resonance imaging (mpMRI). However, PCa suspicion remains based on prostate-specific antigen (PSA) elevation and/or abnormal digital rectal examination (DRE). [...]
2022 - 10.3390/cancers14205100
Cancers, Vol. 14 (october 2022)  
Registro completo - Creative Commons
115.
9 p, 1.7 MB Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The Barcelona magnetic resonance imaging (MRI)-based risk calculator (BCN MRI-RC) exhibited, in the analysed population, better behaviour than the Rotterdam-MRI risk calculator to improve candidate selection for prostate biopsy for the early detection of clinically significant prostate cancer. [...]
2023 - 10.1016/j.euros.2023.03.013
European Urology Open Science, Vol. 53 (may 2023) , p. 46-54  
Registro completo - Creative Commons
116.
16 p, 616.9 KB Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer : An Integrative View / Lee-Rueckert, Miriam (Wihuri Research Institute) ; Lappalainen, Jani (Wihuri Research Institute) ; Kovanen, Petri T. (Wihuri Research Institute) ; Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau)
Atherosclerotic arterial plaques and malignant solid tumors contain macrophages, which participate in anaerobic metabolism, acidosis, and inflammatory processes inherent in the development of either disease. [...]
2022 - 10.3389/fcvm.2022.777822
Frontiers in Cardiovascular Medicine, Vol. 9 (February 2022) , p. 777822  
Registro completo - Creative Commons
117.
26 p, 520.5 KB Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis / Lobato-Delgado, Barbara (Institut d'Investigació Biomèdica Sant Pau) ; Priego-Torres, Blanca (Instituto de Investigación e Innovación Biomédica de Cádiz) ; Sanchez-Morillo, Daniel (Instituto de Investigación e Innovación Biomédica de Cádiz)
Cancer is one of the most detrimental diseases globally. Accordingly, the prognosis prediction of cancer patients has become a field of interest. In this review, we have gathered 43 state-of-the-art scientific papers published in the last 6 years that built cancer prognosis predictive models using multimodal data. [...]
2022 - 10.3390/cancers14133215
Cancers, Vol. 14 Núm. 13 (July 2022) , p. 3215  
Registro completo - Creative Commons
118.
7 p, 264.1 KB European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment / Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ; Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ; Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ; Szmit, S. (Institute of Hematology and Transfusion Medicine) ; Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ; Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ; Jurczak, W. (MSC National Research Institute of Oncology) ; Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ; Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ; Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ; Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ; Parrini, I. (Department of Cardiology. Mauriziano Hospital) ; Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ; Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ; Pudil, R. (University Hospital Hradec Králové. Sokolská) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ; Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ; Farmakis, D. (University of Cyprus Medical School) ; Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ; Stephens, R. (Patient Advocate) ; Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ; Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 - 10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7  
Registro completo - Creative Commons
119.
12 p, 1.1 MB Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer / Lara, Pedro C. (Centro Oncológico Integral de Canarias. Hospital Universitario San Roque. Universidad Fernando Pessoa Canarias) ; Rodríguez-Melcón, Juan I. (Hospital Universitario de Gran Canaria Doctor Negrín. Oncología Radioterápica) ; Palacios-Eito, Amalia (Hospital Universitario "Reina Sofía" (Còrdova). Instituto Maimónides de Investigación Biomédica de Córdoba. Oncología Radioterápica) ; Lozano, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Hervás-Morón, Asunción (Hospital Ramón y Cajal. Oncología Radioterápica) ; Villafranca, Elena (Hospital Universitario de Navarra. Oncología Radioterápica) ; Gómez-Iturriaga, Alfonso (Hospital Universitario Cruces. BioCruces. Oncología Radioterápica) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Maldonado, Xavier (Vall d'Hebron Institut d'Oncologia)
Background: Intermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight gain, loss of libido, and hot flashes. [...]
2022 - 10.3389/fonc.2022.891886
Frontiers in Oncology, Vol. 12 (July 2022) , p. 891886  
Registro completo - Creative Commons
120.
19 p, 630.3 KB The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours / López, Fernando (Instituto Universitario de Oncología del Principado de Asturias) ; Shah, Jatin P. (Sechenov University) ; Beitler, Jonathan J. (Maine General Hospital) ; Snyderman, Carl H. (University of Pittsburgh School of Medicine) ; Lund, Valerie (The Royal National Throat Nose and Ear Hospital. UCLH Foundation Trust) ; Piazza, Cesare (University of Brescia (Itàlia)) ; Mäkitie, Antti A. (Helsinki University Hospital) ; Guntinas-Lichius, Orlando (Jena University Hospital (Alemanya)) ; Rodrigo, Juan P. (Instituto Universitario de Oncología del Principado de Asturias) ; Kowalski, Luiz P. (University of São Paulo Medical School. Department of Head and Neck Surgery) ; Quer, Miquel (Institut d'Investigació Biomèdica Sant Pau) ; Shaha, Ashok (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Homma, Akihiro (Hokkaido University. Graduate School of Medicine) ; Sanabria, Alvaro (CEXCA Centro de Excelencia en Enfermedades de Cabeza y Cuello) ; Ferrarotto, Renata (The University of Texas MD Anderson Cancer Center) ; Lee, Anne W.M. (The University of Hong Kong-Shenzhen Hospital. Clinical Oncology Center) ; Lee, Victor H.F. (The University of Hong Kong-Shenzhen Hospital. Clinical Oncology Center) ; Rinaldo, Alessandra (University of Udine School of Medicine) ; Ferlito, Alfio (International Head and Neck Scientific Group)
Endoscopic endonasal surgery has been demonstrated to be effective in the treatment of selected cases of sinonasal cancers. However, in cases of locally advanced neoplasms, as well as recurrences, the most appropriate approach is still debated. [...]
2022 - 10.1007/s12325-022-02080-x
Advances in Therapy, Vol. 39 Núm. 6 (june 2022) , p. 2379-2397  
Registro completo - Creative Commons
121.
9 p, 203.7 KB Outcomes of men with HIV and germ cell cancer : Results from an international collaborative study / Hentrich, Marcus Ulrich (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Bower, Mark (National Centre for HIV Malignancy. Chelsea and Westminster Hospital) ; Daugaard, Gedske (Department of Oncology. University Hospital Copenhagen. Rigshospitalet) ; Dieing, Annette (Department of Hematology and Oncology. Vivantes Klinikum am Urban) ; Bickel, Markus (Infektiologikum) ; Berretta, Massimiliano (Department of Clinical and Experimental Medicine. University of Messina) ; Lesmeister, Florian (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Jurinovic, Vindi (Institute of Biometrics and Epidemiology. Ludwig Maximilian University of Munich) ; Stoehr, Albrecht (Institute for Interdisciplinary Medicine) ; Heinzelbecker, Julia (Department of Urology and Pediatric Urology. Saarland University Medical Center and Saarland University) ; Krznaric, Ivanka (Practice of Infectious Diseases) ; Dieckmann, Klaus-Peter (Department of Urology. Asklepios Klinik Altona) ; Necchi, Andrea (IRCCS San Raffaele Hospital and Scientific Institute. Vita-Salute San Raffaele University) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Rockstroh, Jürgen Kurt (Department of Medicine I. University Hospital Bonn) ; Brito, Margarida (Instituto Português de Oncologia Francisco Gentil) ; Pfister, David (Department of Urology. University Hospital Cologne) ; Hoffmann, Christian (University Hospital of Schleswig Holstein)
Background: Previous studies have shown that men with HIV and germ cell cancer (HIV-GCC) have inferior overall survival (OS) in comparison with their HIV-negative counterparts. However, little information is available on treatments and outcomes of HIV-GCC in the era of combination antiretroviral therapy (cART). [...]
2022 - 10.1002/cncr.33928
Cancer, Vol. 128 Núm. 2 (January 2022) , p. 260-268  
Registro completo - Creative Commons
122.
19 p, 1.1 MB Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer : Systematic Review on the Performance of Risk Stratification Models / Guerrero-Ramos, F. (Hospital Universitario 12 de Octubre (Madrid). Servicio de Urología) ; Subiela, J.D. (Hospital Ramón y Cajal. Servicio de Urología. Instituto Ramón y Cajal de Investigación Sanitaria. Universidad De Alcalá) ; Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau) ; Aumatell, Julia (Fundació Puigvert. Servicio de Urología) ; Manfredi, Celeste (Unit Of Urology. Department Of Woman. Child And General And Specialized Surgery. University Of Campania 'Luigi Vanvitelli') ; Bozzini, Giorgia (Department Of Urology. Asst Lariana Ospedale Sant'Anna) ; Romero-Otero, Javier (Department Of Urology. Hospital Universitario Hm Sanchinarro) ; Couñago, Felipe (Hospital La Milagrosa)
BACKGROUND: Several classifications have been reported to stratify non-muscle-invasive bladder cancer (NMIBC) in risk groups according to the probability of recurrence and progression. OBJECTIVE: To systematically review the current evidence regarding risk stratification of NMIBC. [...]
2022 - 10.3233/BLC-220055
Bladder Cancer, Vol. 8 Núm. 4 (2022) , p. 339-357  
Registro completo - Creative Commons

Artículos : Encontrados 744 registros   inicioanterior113 - 122siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos